The Efficacy and Safety of Rifaximin Treatment

Hepatic encephalopathy

The Efficacy and Safety of Rifaximin Treatment Characterization of Metabolomic Fingerprints in Patients With Acute Liver Failure and Acute-on-chronic Liver Failure With Hepatic Encephalopathy Comparing Nifuroxazide Plus Lactulose With Lactulose Alone in the Treatment of Hepatic Encephalopathy Intravenous BCAA for HE in ACLF (BCAA-HE-ACLF) Explore the Efficacy and Safety of FMT With Different Bacterial Doses in the Treatment of Hepatic Encephalopathy Role of Bilirubin Molecular Species in Hepatic Encephalopathy and Acute-on-chronic Liver Failure Efficacy of L-Ornithine L-Aspartate (LOLA) as an Adjunct to Branched Chain Amino Acids (BCAA) Enriched Solutions on Clinical Outcomes in ICU Patients With Hepatic Encephalopathy Prevention of Hepatic Encephalopathy With Mobile Application Based Lactulose Titration Allopurinol Versus Simvastatin to Prevent Complications of Liver Cirrhosis Prediction of Post-TIPS Hepatic Encephalopathy in Patients With Liver Cirrhosis Diagnosing Minimal Hepatic Encephalopathy Speech in Hepatic Encephalopathy (HE) Immune Profile, Neuronal Dysfunction, Metabolomics and Ammonia in Therapeutic Response of HE in ACLF Effect of Brief Dietary Intervention on Ammonia Levels Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhotic Patients Efficacy and Safety of Fecal Microbiota Transplant for Secondary Prophylaxis of Hepatic Encephalopathy GELSECTAN® and Covert Hepatic Encephalopathy Early Diagnosis and Timely Treatment of Cirrhotic Patients With Minimal Hepatic Encephalopathy (CHESS-NCRCID 2106) Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis A Randomized Open-label Trial of Deprescribing Proton Pump Inhibitors to Reduce the Risk of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Creation Feasibility of an App-based Nutrition & Exercise Program in Cirrhosis Eye Movement Testing for Diagnosing Encephalopathy in Patients With Liver Disease VE303 for Treatment of Hepatic Encephalopathy (HE) Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy The Effect of Induced Hyperammonaemia on Sleep and Melanopsin-mediated Pupillary Light Response in Patients With Liver Cirrhosis Microbial Resistance of Rifaximin in Hepatic Encephalopathy Establishment of the Human Intestinal and Salivary Microbiota Biobank – Gastrointestinal Diseases The BRAINFOOD Trial to Prevent Recurrent Hepatic Encephalopathy. HepQuant to Predict Hepatic Encephalopathy After TIPS Polyethylene Glycol Versus Lactulose on Hepatic Encephalopathy in Patients With Cirrhosis;(PEGHE Trial) Flicker App for Minimal Hepatic Encephalopathy Prognostic Significance of Fatty Liver Disease in Bariatric Patients Timing of Acute Palliative Care Consultation in Critically Ill Patients Effects of Branched-Chain Amino Acids on Muscle Ammonia Metabolism in Patients With Cirrhosis and Healthy Subjects The Effect of Prometheus (R) Liver Support Dialysis on Cerebral Metabolism in Acute Liver Failure Tackling 30-day Readmissions in Patients With Cirrhosis: The SALTYFOOD Trial The Effect of a Large-volume Paracentesis on Fatigue, Sleep, and Quality of Life in Cirrhosis Factors Associated With End Stage Liver Disease A Multi-Center Group to Study Acute Liver Failure in Children Monitoring of Encephalopathy in Cirrhotic Patients Admitted in Intensive Care A Study of MHE in Patients With Liver Diseases Effect of Midodrine and Albumine in the Prevention of Complications in Cirrhotic Patients Awaiting Liver Transplantation Effect of Transjugular Intrahepatic Portosystemic Shunt on Gut Microbiota in Cirrhotic Patients Quantitative Determination of Brain Water Content in Patients During and After Hepatic Encepalopathy Prediction of Mortality in Patients Waiting for Liver Transplantation Through Brain Magnetic Resonance Imaging Oral Fecal Transplant in Cirrhosis Bioelectrical Impedance Vector Analysis in Cirrhotic Patients Therapeutic Efficacy of Oral L-Ornithine-L-Aspartate on Minimal Encephalopathy Trial Comparing Sedation for Endoscopy With Propofol Versus Midazolam in Cirrhotics Manganese in Women With Encephalopathy Brain Energy Metabolism in Patients With Chronic Liver Disease and Impaired Central Nervous System Comparison Between Lactulose and Lactulose-Paraffin in Cirrhotic Patients Early Postoperative CRRT After Liver Transplantation in ACLF Patients With Overt HE N-acetylcysteine in Non-Acetaminophen Pediatric Acute Liver Failure Effect of Probiotics in Treatment of Minimal Hepatic Encephalopathy (MHE) and Health Related Quality of Life Study of Lactulose in Children With Chronic Liver Disease Reversibility of Minimal Hepatic Encephalopathy Following Liver Transplantation MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy) A Randomized Comparison of Rifaximin Versus Lactulose in Hospitalized Cirrhotic Patients With Renal Failure A Study of Controlled Lactulose Withdrawal Brain Imaging in Patients With Chronic Liver Disease and Functional Impairment. Investigational Microbiota Restoration Therapeutic for Hepatic Encephalopathy FMT in Cirrhosis and Hepatic Encephalopathy Minimal HePatic Encephalopathy Among CiRrhotics. A Cross SEctional, Clinico-EpidEmiological, Multi-Centre, Study in Patients of PakisTan Cerebral Oxygen, Blood Flow and Ammonia Uptake in Patients With Cirrhosis and an Acute Episode of Hepatic Encephalopathy (HE) Antioxidants and Zinc Improving Minimal Hepatic Encephalopathy In Truck Drivers; a Pilot Study iPod Games in Hepatic Encephalopathy MNK-6105 for Patients With Cirrhosis and High Ammonia Levels Affecting Brain Function Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS) Effect of Rifaximine on Sleep Disorders in Patients Suffering From Hepatic Encephalopathy Rifamycin in Minimal Hepatic Encephalopathy HEAL STUDY (Hepatic Encephalopathy and Albumin Study) Fecal Transplant in Recurrent Hepatic Encephalopathy Intravenous Branched Chain Amino Acids for Hepatic Encephalopathy in ACLF A Nutritional Approach to Minimal Hepatic Encephalopathy Efficacy of Sildenafil in the Improvement of Cognition and Quality of Life in Patients With Cirrhosis of Liver. A Proof of Concept Study. Oral Acetyl-L-Carnitine Therapy Reduces Fatigue In Hepatic Encephalopathy PEG3350 in ACLF With Hepatic Encephalopathy S. Endotoxin, Inflammatory Mediators and MRS Before and After Treatment in MHE Effect of Music on Attention and Prospective Memory in Hepatic Encephalopathy Albumin Infusion Effects in Mortality in Patients With Cirrhosis and Hepatic Encephalopathy The Safety/Efficacy of Rifaximin With/Without Lactulose in Participants With A History of Recurrent Hepatic Encephalopathy Real World Outcomes Study of Hepatic Encephalopathy Patients’ Experience on Rifaximin (PROSPER) Study of Rifaximin in Minimal Hepatic Encephalopathy PEG (Polyethylene Glycol)Versus Lactulose For Treatment Of Overt Hepatic Encephalopathy A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy Safety and Tolerability Study of Rifaximin in Participants With a History of Hepatic Encephalopathy L-ornithine L-aspartate in Overt Hepatic Encephalopathy Efficacy and Safety of Nitazoxanide in Preventing Recurrence of Hepatic Encephalopathy Efficacy Study of Polyethylene Glycol 3350-electrolyte Solution (GoLYTELY®) Versus Lactulose in Patients With Hepatic Encephalopathy. Efficacy of Albumin for Acute Encephalopathy in Patients With Cirrhosis Lactulose for the Prevention of Hepatic Encephalopathy in Cirrhotic Patients With Upper Gastrointestinal Hemorrhage Default Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy Outcome AST-120 Used to Treat Mild Hepatic Encephalopathy The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy Rifaximin Plus Lactulose Versus Lactulose Alone for the Treatment of Hepatic Encephalopathy: a Double Blind Randomized Trial Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy Late Evening and Early Morning Protein Supplement to Reduce Readmissions for Hepatic Encephalopathy Rifaximin’s Effect on Covert Hepatic Encephalopathy in Cirrhosis Patients With Small Intestinal Bacterial Overgrowth and Gastrointestinal Dysmotility Coenzyme Q10 and Meclofenoxate in Hepatic Encephalopathy Effect of Yogurt on Minimal Hepatic Encephalopathy Probiotic Lactobacillus GG (LGG) in Patients With Minimal Hepatic Encephalopathy Efficacy of Combined Oral L-Ornithine-L-Aspartate and Lactulose in Patients With Hepatic Encephalopathy Acetyl-L-Carnitine Reduces Depression and Improves Quality of Life in Patients With Minimal Hepatic Encephalopathy Efficacy of L-Ornithine L-Aspartate in Acute Hepatic Encephalopathy. Efficacy of L-Ornithine-L-Aspartate in Cirrhotics With Hepatic Encephalopathy Transcranial Doppler Ultrasound and Minimal Hepatic Encephalopathy Brain Muscle Axis During Treatment of Hepatic Encephalopathy With L-ornithine L-aspartate Effect of Lactose in Patients With Chronic Liver Disease and Minimal Hepatic Encephalopathy Fecal Microbiota Transplantation (FMT) in the Management of Hepatic Encephalopathy (HE): a Pilot Study Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy The Effects of Nitazoxanide in Hepatic Encephalopathy Effect of Lactulose on Minimal Hepatic Encephalopathy and Health-Related Quality of Life A 6-month Efficacy, Safety, and Tolerability Study of Rifaximin In Preventing Hepatic Encephalopathy Diagnosis of Covert/Minimal Hepatic Encephalopathy by Means of Continuous Reaction Time Measurement Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE) Rifaximin Soluble Solid Dispersion (SSD) Tablets Plus Lactulose for the Treatment of Overt Hepatic Encephalopathy (OHE) Fecal Transplant for Hepatic Encephalopathy RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy – A Randomized, Controlled Trial Post Transjugular Intrahepatic Portosystemic Shunt (Tips) Albumine Infusion to Prevent Hepatic Encephalopathy Effects of Proteins in Patients With Cirrhosis and Prior Hepatic Encephalopathy A Retrospective, Open-label, Uncontrolled Cohort Study to Assess the Effectiveness and Safety of Lactulose Retention Enema in the Treatment of Cirrhotic Patients With Grade 3 or 4 (West Haven Criteria) Hepatic Encephalopathy (HE) [The RETRO Study] Fecal Microbiota Transplant as Treatment of Hepatic Encephalopathy Rifaximin in Minimal Hepatic Encephalopathy Role of MRI in Detection of Minimal Hepatic Encephalopathy Cerebrovascular Reactivity in Hepatic Encephalopathy Primary Prophylaxis of Hepatic Encephalopathy in Patients With Cirrhosis Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhosis Secondary Prophylaxis of Hepatic Encephalopathy With a Probiotic Preparation The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy. Metformin Experience on Minimal Hepatic Encephalopathy Hyperproteic Diet Plus Lactobacillus Reuteri and Nitazoxanide in Minimal Hepatic Encephalopathy Comparison Between Erythromycin and Neomycin Treatment of Hepatic Encephalopathy Plasma Free Amino Acids in Patients With Hepatic Encephalopathy Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRS Lactulose, L-ornithine L-aspartate, or Rifaximin Versus Placebo for Preventing Hepatic Encephalopathy in Variceal Bleeding Low-dose Rifaximin in the Treatment of Covert Hepatic Encephalopathy